AMED News and Press, Amedisys Inc From 04/28/22

Gainers: SQZ Biotechnologies (SQZ) +20%. Amedisys (AMED) +7%. Thermo Fisher Scientific (TMO) +7%. Vascular Biogenics (VBLT) +5%. Opiant Pharmaceuticals (OPNT) +4%. Losers: Teladoc Health (TDOC) -46%. Align Technology (ALGN) -23%. Aptorum Group (APM) -19...

The following slide deck was published by Amedisys, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Amedisys, Inc. 2022 Q1 - Results - Earnings Call Presentation

Amedisys  press release (NASDAQ:AMED): Q1 Non-GAAP EPS of $1.23 beats by $0.11. Revenue of $545.3M (+1.5% Y/Y) misses by $13M. For further details see: Amedisys Non-GAAP EPS of $1.23 beats by $0.11, revenue of $545.3M misses by $13M

BATON ROUGE, La., April 27, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2022. Three-Month Periods Ended March 31, 2022 and 2021 Net service revenue increased $8.2 millio...

BATON ROUGE, La., April 26, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, announces the promotion of Nick Muscato to Chief Strategy Officer, effective immediately. “I am thrilled to a...

The global home healthcare market could be worth $839 billion by 2028, says Zion Market Research, which could be a significant catalyst for companies such as Quipt Home Medical Corp. (NASDAQ: QIPT) (TSXV: QIPT), Amedisys Inc. (NASDAQ: AMED), LHC Group Inc. (NASDAQ: LHCG), Sava...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

BATON ROUGE, La., April 13, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the first quarter ended March 31, 2022, after the market closes on April 27, 2022. The Company ...

BATON ROUGE, La., April 04, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, has closed on its acquisition of Evolution Health, LLC, a provider of home health services. Evolution Health, LLC, a di...

BATON ROUGE, La., April 04, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, has closed on its acquisition of certain home health assets from AssistedCare Home Health, Inc., and RH Homecare Servic...